InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Browse the full record of transactions filed by Sherman Matthew L, EVP et Directeur Médical. Insider active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. In total, 9 reports have been published. Total volume traded: €186k. The latest transaction was filed on 16 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€18,0211,768 shares@ €10.19269.7% of flow
Common Stock
SEC:0001209191-22-038432:0·
€7,841984 shares@ €7.96884.2% of flow
Common Stock
SEC:0001209191-22-011361:0·
€7,841984 shares@ €7.96889.4% of flow
Common Stock
SEC:0001209191-22-011361·
020,500 shares0
Common Stock
SEC:0001209191-22-004076·
020,500 shares0
Common Stock
SEC:0001209191-22-004076:0·
011,100 shares0
Common Stock
SEC:0001209191-21-070232·
011,100 shares0
Common Stock
SEC:0001209191-21-070232:0·
€75,9132,659 shares@ €28.549490.6% of flow
Common Stock
SEC:0001209191-21-059804·
€75,9132,659 shares@ €28.549440.9% of flow
Common Stock
SEC:0001209191-21-059804:0·
9 of 9 declarations
About Sherman Matthew L
Matthew L. Sherman serves as EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. He is responsible for leading the company's medical and research initiatives. Matthew plays a key role in developing innovative treatments and improving patient outcomes. His medical expertise is essential for Deciphera's mission.
